QX2-25216-82927
5 vaccinations
5 coded responses
15 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 950 / CA
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Registered dependents
5PA-33123-82263
Child or adolescent in my care · Male · 2022-07-18
Timeline
-
2021-03-08
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-26
Registered in v-safe
- 2021-03-26
- 2021-03-29
- 2021-04-05
-
2021-06-02
Dose 2 — Pfizer-BioNTech
- 2021-06-07
-
2021-06-23
Dose 3 — Pfizer-BioNTech
- 2021-09-13
-
2021-12-22
Survey response — 6 months, dose 3MedDRA: Influenza — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Got fluMedDRA releases: 2024-11 · check-in free text available
-
2021-12-22
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-23
Call successfulParticipant prefers to complete VAERS report online
-
2021-12-25
Dose 4 — Pfizer-BioNTech
- 2022-06-23
-
2022-11-03
Dose 5 — Pfizer-BioNTech
-
2022-11-09
Survey response — days 1–6 daily, dose 5MedDRA: Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea, Upper-airway cough syndrome — Feeling: PoorFree text: Throat pain, runny nose, postnasal drip, chest congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-10
Survey response — day 7, dose 5MedDRA: Cough, Rhinorrhoea — Feeling: PoorFree text: Runny nose, coughingMedDRA releases: 2024-11 · check-in free text available
- 2022-11-17
- 2022-11-24
- 2022-12-12
- 2022-12-15
-
2023-02-02
Survey response — 3 months, dose 5MedDRA: Arthralgia, Chills, Diarrhoea, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-05-04
Survey response — 6 months, dose 5MedDRA: Bone pain, Cough, Nasal ulcer, Oropharyngeal pain, Peripheral swelling, Rhinorrhoea, Upper-airway cough syndrome — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-06-02 | Pfizer-BioNTech | No |
| 3 | 2021-06-23 | Pfizer-BioNTech | No |
| 4 | 2021-12-25 | Pfizer-BioNTech | No |
| 5 | 2022-11-03 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — 6 months, dose 3
Symptoms: Got flu
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Throat pain, runny nose, postnasal drip, chest congestion
Release 12 — day 7, dose 5
Systemic reaction (other): Runny nose, coughing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Bone pain | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasal ulcer | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Peripheral swelling | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release